These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1233532)

  • 1. Spectral maps of the Liege-physiognomies of the neuroleptics.
    Lewi PJ
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Dec; 8(6):375-9. PubMed ID: 1233532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pharmacological spectral maps of the neuroleptics.
    Lewi PJ
    Int Pharmacopsychiatry; 1976; 11(3):181-9. PubMed ID: 992957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectral mapping, a technique for classifying biological activity profiles of chemical compounds.
    Lewi PJ
    Arzneimittelforschung; 1976; 26(7):1295-1300. PubMed ID: 1036914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extra-pyramidal syndrome caused by neuroleptics].
    Lambert PA
    Encephale; 1973; 62(1):78-105. PubMed ID: 4718697
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical classification of neuroleptics, with special reference to their antimanic, antiautistic, and ataraxic properties.
    Bobon J; Pinchard A; Collard J; Bobon DP
    Compr Psychiatry; 1972 Mar; 13(2):123-31. PubMed ID: 5010592
    [No Abstract]   [Full Text] [Related]  

  • 6. The Liege physiognomy of neuroleptics, with special reference to thioxanthenes.
    Bobon DP; Gottfries CG
    Acta Psychiatr Belg; 1974 Sep; 74(5):535-44. PubMed ID: 4471035
    [No Abstract]   [Full Text] [Related]  

  • 7. Definition and classification of neuroleptics.
    Arnold OH; Collard J; Deniker P; Ginestet D; Hippius H; Itil TM; Labhardt F; Leeds AA; Montanini R; Morozov G; Simon P; Villeneuve A
    Mod Probl Pharmacopsychiatry; 1970; 5():141-7. PubMed ID: 5527163
    [No Abstract]   [Full Text] [Related]  

  • 8. Scandinavian standpoint on the Liege classification of neuroleptics.
    Kristjansen P
    Acta Psychiatr Belg; 1974 Sep; 74(5):462-9. PubMed ID: 4157189
    [No Abstract]   [Full Text] [Related]  

  • 9. [Statokinesimetric and clinical study of extrapyramidal disorders induced by neuroleptics in a population of mental patients].
    Andersson JC; Morel P; Poilpre E; Baron JB
    Agressologie; 1977; 18 Spec No():35-43. PubMed ID: 900359
    [No Abstract]   [Full Text] [Related]  

  • 10. An attempt to classify neuroleptic drugs on the basis of short-term clinical comparative studies.
    Rodová A; Náhunek K; Svestka J
    Act Nerv Super (Praha); 1974 Aug; 16(3):169-70. PubMed ID: 4609274
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trial of tropatepine chlorhydrate as a corrector of syndromes due to neuroleptics].
    Delaunay J; Guibert S
    Ann Med Psychol (Paris); 1976 Jan; 1(1):144-7. PubMed ID: 970819
    [No Abstract]   [Full Text] [Related]  

  • 12. [Delayed-action neuroleptics (sustained-release neuroleptics). Indications, advantages and side effects].
    Predescu V; Nica-Udangiu St
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1975; 20(4):287-96. PubMed ID: 1085475
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adverse effects in the treatment with neuroleptics].
    Malá E
    Cesk Pediatr; 1976 May; 31(5):270-2. PubMed ID: 132306
    [No Abstract]   [Full Text] [Related]  

  • 14. The neuroleptics. 10. Therapeutic problems.
    Barahona-Fernandes HJ; Cazzullo CL; Cocchi A; Denber HC; Freyhan FA; Klerman GL; Köknel O; Levine J; Saarma J; Sarteschi P; Vinar O; Wittenborn JR
    Mod Probl Pharmacopsychiatry; 1970; 5():148-56. PubMed ID: 4949818
    [No Abstract]   [Full Text] [Related]  

  • 15. [Letter: Tardive dyskinesia, a little-known extrapyramidal syndrome due to therapy with neuroleptics].
    Berchtold P; Hinssen M; Irmscher K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):420-1. PubMed ID: 4151333
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antagonism between anti-Parkinson drugs and neuroleptics. Apropos of various withdrawal experiences, a personal one among them (2nd part)].
    Bourgeois M; Bouey P
    Ann Med Psychol (Paris); 1976 Nov; 2(4):669-708. PubMed ID: 1020864
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neuroleptics: functional and biochemical effects].
    Anden NE
    Lakartidningen; 1972 Mar; 69():71-7 passim. PubMed ID: 4664127
    [No Abstract]   [Full Text] [Related]  

  • 18. Classification and discrimination for data analysis in pharmacology.
    Lewi PJ; van Bever WF; Janssen PA
    Eur J Pharmacol; 1976 Feb; 35(2):403-7. PubMed ID: 1248515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cellular effect of neuroleptics].
    Kuschinsky K
    Dtsch Med Wochenschr; 1975 Jun; 100(25):1405-8. PubMed ID: 237751
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuroleptic manifestations in daily practice].
    Stojanović T; Savić B; Todorović M
    Med Pregl; 1978; 31(1-2):63-5. PubMed ID: 651834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.